transitioning from tirzepatide to retatrutide Switching retatrutide: the complete transition guide Comparing the Big 3, Semaglutide,

Novo Nordisk is offering a cheaper and equally good alternative Convenience is often the most underrated form of innovation

Kubota S, Yabe D

Integrated Support Our plans combine injections with dietary guidance, exercise coaching, and optional therapies like GLP-1 or glutathione to optimize results

With 19 approved therapies already on the market and an active clinical pipeline spanning hundreds of programs, the ADC sector has moved well past proof-of-concept and into a sustained commercial expansion Antibody Discovery Services and Platforms Market to Reach $6.3 Billion by 2035 a The global antibody discovery market, valued at $2.0 billion in 2025, will climb to $2.2 billion in 2026 and reach $6.3 billion by 2035, compounding at a CAGR of 12.3% over the forecast period